Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Frieman

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Nature Communications|May 25, 2023
A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8Bruno A Rodriguez-Rodriguez, Grace O Ciabattoni, Ralf Duerr, et al.
Plos Genetics|October 10, 2015
Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative CrossLisa E Gralinski, Martin T Ferris, David L Aylor, et al.
Iscience|November 21, 2024
The BNT162b2 mRNA vaccine demonstrates reduced age-associated T<sub>H</sub>1 support <i>in vitro</i> and <i>in vivo</i>Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, et al.
Research Square|January 4, 2023
The mRNA vaccine BNT162b2 demonstrates impaired T<sub>H</sub>1 immunogenicity in human elders <i>in vitro</i> and aged mice <i>in vivo</i>Byron Brook, Benoit Fatou, Abhinav Kumar Checkervarty, et al.
Nature Communications|February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsJames Logue, Robert M Johnson, Nita Patel, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle ReplicationXin Yin, Yuan Pu, Shuofeng Yuan, et al.
Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Science Translational Medicine|February 19, 2016
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivoThomas Luke, Hua Wu, Jincun Zhao, et al.
The New England Journal of Medicine|September 3, 2020
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle VaccineCheryl Keech, Gary Albert, Iksung Cho, et al.
Nature Communications|January 15, 2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceJing-Hui Tian, Nita Patel, Robert Haupt, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Nature Communications|May 25, 2023
A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8Bruno A Rodriguez-Rodriguez, Grace O Ciabattoni, Ralf Duerr, et al.
Plos Genetics|October 10, 2015
Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative CrossLisa E Gralinski, Martin T Ferris, David L Aylor, et al.
Iscience|November 21, 2024
The BNT162b2 mRNA vaccine demonstrates reduced age-associated T<sub>H</sub>1 support <i>in vitro</i> and <i>in vivo</i>Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, et al.
Research Square|January 4, 2023
The mRNA vaccine BNT162b2 demonstrates impaired T<sub>H</sub>1 immunogenicity in human elders <i>in vitro</i> and aged mice <i>in vivo</i>Byron Brook, Benoit Fatou, Abhinav Kumar Checkervarty, et al.
Nature Communications|February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsJames Logue, Robert M Johnson, Nita Patel, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle ReplicationXin Yin, Yuan Pu, Shuofeng Yuan, et al.
Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Science Translational Medicine|February 19, 2016
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivoThomas Luke, Hua Wu, Jincun Zhao, et al.
The New England Journal of Medicine|September 3, 2020
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle VaccineCheryl Keech, Gary Albert, Iksung Cho, et al.
Nature Communications|January 15, 2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceJing-Hui Tian, Nita Patel, Robert Haupt, et al.
Pageof 11